aTYR PHARMA INC Quarterly Return On Equity in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
aTYR PHARMA INC quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q2 2024.
  • aTYR PHARMA INC Return On Equity for the quarter ending June 30, 2024 was -65.4 %, a 32% decline year-over-year.
  • aTYR PHARMA INC annual Return On Equity for 2023 was -49.8 %, a 8.45% increase from 2022.
  • aTYR PHARMA INC annual Return On Equity for 2022 was -54.4 %, a 27.7% decline from 2021.
  • aTYR PHARMA INC annual Return On Equity for 2021 was -42.6 %, a 7.15% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -65.4 -15.9 -32% Apr 1, 2024 Jun 30, 2024
Q1 2024 -56.9 -4.5 -8.59% Jan 1, 2024 Mar 31, 2024
Q4 2023 -49.8 +4.6 +8.45% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44.8 +5.2 +10.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.5 -9.84 -24.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -52.4 -10 -23.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -54.4 -11.8 -27.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -50 +0.38 +0.75% Jul 1, 2022 Sep 30, 2022
Q2 2022 -39.7 +35.9 +47.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42.4 +25.1 +37.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.6 +3.28 +7.15% Oct 1, 2021 Dec 31, 2021
Q3 2021 -50.4 +2.36 +4.47% Jul 1, 2021 Sep 30, 2021
Q2 2021 -75.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 -67.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 -45.9 Oct 1, 2020 Dec 31, 2020
Q3 2020 -52.8 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.